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severity, and outcomes for surgical
oncology patients
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Background. Patients and payers wish to identify hospitals with good surgical oncology outcomes. Our
objective was to determine whether differences in outcomes explained by hospital structural characteristics
are mitigated by differences in patient severity.
Methods. Using hospital administrative and cancer registry records in Pennsylvania, we identified
24,618 adults hospitalized for cancer-related operations. Colorectal, prostate, endometrial, ovarian,
head and neck, lung, esophageal, and pancreatic cancers were studied. Outcome measures were 30-day
mortality and failure to rescue (FTR) (30-day mortality preceded by a complication). After severity of
illness adjustment, we estimated logistic regression models to predict the likelihood of both outcomes. In
addition to American Hospital Association survey data, we externally verified hospitals with National
Cancer Institute (NCI) cancer center or Commission on Cancer (COC) cancer program status.
Results. Patients in hospitals with NCI cancer centers were significantly younger and less acutely ill on
admission (P < .001). Patients in high volume hospitals were younger, had lower admission acuity, yet
had more advanced cancer (P < .001). Unadjusted 30-day mortality rates were lower in NCI-designated
hospitals (3.76% vs 2.17%; P = .01). Risk-adjusted FTR rates were significantly lower in NCI-des-
ignated hospitals (4.86% vs 3.51%; P = .03). NCI center designation was a significant predictor of
30-day mortality when considering patient and hospital characteristics (OR, 0.68; 95% CI, 0.47--0.97;
P = .04). We did not find significant outcomes effects based on COC cancer program approval.
Conclusion. Patient severity of illness varies significantly across hospitals, which may explain the
outcome differences observed. Severity adjustment is crucial to understanding outcome differences.
Outcomes were better than predicted for NCI-designated hospitals. (Surgery 2010;147:602-9.)From the Division of Nursing Business and Health Systems, School of Nursing, University of Michigan,a
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URGERYIn addition, tumor-directed surgical procedures
are being performed with increasing frequency
on patients of increasing age and related comor-
bidities. Variations in outcomes from surgical on-
cology procedures are widely reported; the
majority of these studies have focused on outcome
differences by procedure volume,1-5 or receipt of
care in a hospital recognized by the National Can-
cer Institute (NCI) cancer center program.6 The
quality gap observed in surgical oncology out-
comes might worsen, given the increased attention
to provide anti-cancer therapies to older adults,
many of whom may have comorbidities.7
Based on research findings, stakeholder groups
in the United States have suggested that rare or
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by physicians or hospitals achieving certain annual
case volume targets.8 In 1992, Canadian provinces
began the process of regionalizing cardiac proce-
dures in response to documented variations in out-
come.9 Similar proposals might be considered for
receipt of surgical oncology care in facilities
achieving certain benchmarks, such as NCI Cancer
Center or the Commission on Cancer (COC) can-
cer program status.10 At the time of this study, NCI
clinical cancer center designation required robust
clinical and basic science research programs that
underwent peer- and site-review.11 In addition,
comprehensive cancer center designation required
shared research resources, as well as a cancer con-
trol and population science research program.
The COC program credential required: state-of-
the-art clinical services that span the phases of di-
agnosis through completion of treatment; a cancer
committee leadership program; care conferences
where patient cases are discussed and continuing
education is provided, and an established cancer
registry.10 These credentials were confirmed by
a formal site visit conducted by COC members.
Before options to redirect patients with cancer
to credentialed facilities are considered, additional
research is needed to ascertain if and why differ-
ences in quality exist, and to rigorously examine
the outcome differences in multiple datasets.
As part of our team’s research program in eluci-
dating the relationship between nursing care and
surgical patient outcomes,12,13 we studied outcomes
in a sample of surgical oncology patients admitted
to Pennsylvania hospitals in 1998--1999. Mortality
outcomes were superior when patients received
care in hospitals with better nurse staffing, more
favorable nurse perceptions of their workplace,
and nurses with higher educational preparation.14
One intriguing finding that we follow up on in
this study is that the only significant hospital charac-
teristic associated with more favorable outcomes---
in addition to nursing factors---was NCI cancer cen-
ter designation. This paper extends our previous re-
search to examine more closely the array of hospital
and patient characteristics and their relationship to
patient outcomes using enhanced patient severity
adjustment. Do certain types of hospitals---includ-
ing those with cancer specialty designation---have
better outcomes for surgical oncology patients? To
what extent are differences in patient outcomes, if
found, explained by patient characteristics? The
findings are pertinent to clinical and payer practices
that encourage referrals to hospitals with specific
organizational characteristics.PATIENTS AND METHODS
After human subjects exempt review, we per-
formed secondary analysis of linked data created
by merging inpatient claims from the Pennsylvania
Health Care Cost Containment Council, the Penn-
sylvania Cancer Registry, and the American Hospi-
tal Association annual survey data. The list of
National Cancer Institute’s11 clinical and compre-
hensive cancer centers available from the NCI’s
website, and a list of approved cancer programs
provided by the American College of Surgeons,
were used to identify hospitals in the sample
with those designations in 1998--1999. Details
of the linkage procedure have been reported
elsewhere.14
Our analytic sample included 24,618 adults
treated in 164 acute care hospitals in 1998--1999
with a diagnosis and surgical procedure for one of
the following cancers: head and neck, esophagus,
colon-rectum, pancreas, lung, ovary, prostate, and
endometrium. Breast cancer patients were ex-
cluded from this analysis because of their signifi-
cantly shorter lengths of hospital stay.
Definition of variables. Hospital characteristics:
Whenever possible, existing definitions from the
outcomes research literature focused on hospital
characteristics were used. Hospital beds set up and
staffed were categorized as: 100 beds or fewer, 101--
250 beds, 251 beds or higher.12 Hospitals that per-
formed solid organ or open heart transplants in
1999 were coded as providers of ‘‘advanced proce-
dures.’’15 Prior studies have suggested the provi-
sion of advanced technological resources may
have spillover effects for other conditions.16 We
used the ratio of medical residents or fellows per
beds set up and staffed to categorize teaching
status: Nonteaching hospitals had no residents/
fellows per bed; minor teaching hospitals had a
lower than 1:4 resident/fellow to bed ratio; major
teaching hospitals had at least one resident/fellow
per 4 beds.17,18 We constructed quartiles of hospi-
tal procedure volume for the total number of pro-
cedures performed at each hospital on our set of
ICD-9 diagnosis codes for the years 1998 and
1999.19 For example, hospitals received credit for
all right hemi-colectomies performed, regardless
of whether the underlying diagnosis was for malig-
nancy. Dichotomous variables were created to
reflect whether a hospital had received cancer cen-
ter or cancer program status by the NCI or COC,
respectively.
Clinical severity: Tumor registry data were com-
bined with hospital claims to measures patients’
risk for poor outcomes. We then estimated logistic
Table I. Clinical severity by hospital characteristics
NCI center COC program
Procedure volume
quartile
Full sample No Yes No Yes Lowest 2nd 3rd
n 164 160 4 85 79 41 42 40
N 24,618 22,778 1,840 7,453 17,165 1,601 3,595 6,179
Age mean (SD) 68.3 (12.2) 68.7 (12.2) 63.2 (12.1) 69.6 (10.6) 67.8 (12.3) 71.6 (11.9) 70.1 (11.9) 69.4 (11.8)
P value <.0001 <.0001 <.0001
Comorbidity
None 86.7 87.0 82.4 86.4 86.8 84.0 87.0 87.9
1 4.2 3.9 7.0 4.4 4.1 4.8 3.9 3.5
2 3.9 3.8 4.7 4.0 3.8 3.9 3.8 3.9
3 or more 5.3 5.3 5.9 5.2 5.4 7.3 5.2 4.7
P value <.0001 .52 <.01
Atlas Severity Score
0 13.5 13.5 13.6 13.2 13.6 10.4 12.3 12.3
1 33.9 33.5 39.0 30.5 35.3 24.9 29.0 32.6
2 36.0 36.1 34.7 39.6 34.5 44.2 40.5 36.9
3 or 4 16.6 16.9 12.7 16.7 16.6 20.5 18.3 18.3
P value <.0001 <.0001 <.0001
Distant cancer 13.2 13.2 13.2 12.3 13.6 12.6 12.4 11.9
P value .97 <.01 .0001
P values reported reflect significance test for t or F tests for age by hospital characteristics, or Chi-square tests for categorical variables by hospital
characteristics.
NCI, National Cancer Institute Clinical or Comprehensive Cancer Center; COC, Commission on Cancer Approved Cancer Program.
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failure to rescue using split-sample methodology.
In a random fifty percent sample of the patients,
83 logistic regression models with a single cova-
riate reflecting a patient characteristic were esti-
mated to predict 30-day mortality.20 Patient
variables with significant coefficients at P # .10
were retained in the severity model (a list of the
final variables and the coefficients is available
from the author). The model was replicated
in the remaining 50% of the sample, with no corre-
sponding differences in coefficients and signifi-
cance observed. The retained 25 variables
reflected demographics, comorbidity, and cancer
information. Model discrimination for the full
sample, reflected by the C statistic, was 0.83 for
mortality and 0.76 for failure to rescue.21 Age was
measured as both a linear and quadratic term.
Non-white ethnicity was not a statistically signifi-
cant variable in the severity model. While this
may be partially explained by low numbers of
non-white patients in Pennsylvania, we chose to re-
tain the variable in our models to account for un-
measured socioeconomic differences by race and
ethnicity. Results did not change when this variable
was excluded from the model. By state regulations,
each hospital admission in Pennsylvania was ab-
stracted routinely by trained medical records
coders for key clinical findings to construct theAtlas (formerly known as MEDISGRPS) severity
of illness score.22-24 In contrast to usual methods
of measuring severity using diagnosis and proce-
dure codes, the Atlas score uses data from the
medical record to measure physiologic data, such
as unstable vital signs, abnormal laboratory, radiol-
ogy, or diagnostic test results. For each hospitaliza-
tion, the resulting score is reported as a categorical
variable (0 = no probability of inpatient mortality
to 4 = >0.5 probability of inpatient mortality).
Based on an existing severity adjustment ap-
proach,20 we constructed an algorithm to detect
comorbidities from claims data up to 90 days pre-
ceding the studied admission, and each comorbid-
ity was treated as a dichotomous variable. Tumor
type was treated as a categorical variable, length
of cancer diagnosis (in months) was a continuous
measure, and a dichotomous measure was used
to reflect distant or systemic cancer stage.
Outcomes: The two dichotomous outcomes were
obtained by the linkage of death records to the
cancer registry and inpatient claims records. 30-day
mortality is the occurrence of death within 30 days of
hospital admission. Failure to rescue (FTR) is a
death within 30 days of hospital admission for
patients who have also experienced a postoperative
complication.25,26 A set of diagnosis and procedure
codes (that were not coded in the 90 days prior to ad-
mission) are the basis for 40 complications
Table I. (continued)
Procedure volume
quartile Bedsize Teaching intensity Advanced procedures
Highest <100 100--250 >250 None Minor Major No Yes
41 21 97 46 84 68 12 105 59
13,243 1,033 10,888 12,697 8,386 11,932 4,300 9,785 14,833
66.9 (11.8) 68.9 (13.3) 69.3 (12.0) 67.4 (12.2) 70.1 (11.9) 68.2 (12.2) 65.1 (12.2) 69.6 (12.0) 67.4 (12.3)
<.0001 <.0001 <.0001
86.3 83.7 87.8 86.0 87.7 87.0 84.2 87.4 86.2
4.5 6.6 3.6 4.4 3.9 4.0 5.1 3.9 4.3
3.8 3.0 3.6 4.1 3.4 3.9 4.7 3.7 3.9
5.4 6.7 5.0 5.5 5.0 5.3 6.1 5.0 5.5
<.0001 <.0001 .08
14.7 11.7 13.4 13.7 12.3 13.8 15.1 12.8 14.0
36.9 27.0 31.6 36.4 31.2 34.4 37.5 31.2 35.6
33.5 40.7 37.3 34.6 38.2 35.0 34.7 38.7 34.3
14.9 20.6 17.7 15.3 18.3 16.8 12.7 17.4 16.1
<.0001 <.0001 <.0001
14.1 14.0 12.7 13.6 12.2 13.1 15.5 12.7 13.5
.07 <.0001 .07
Table II. Unadjusted and risk-adjusted hospital-level outcome rates by hospital characteristics
30-day mortality Failure to rescue
% (SD)
F or t,
P value % (SD)
F or t,
P value % (SD)
F or t,
P value % (SD)
F or t,
P value
Hospital characteristic Unadjusted Adjusted Unadjusted Adjusted
Teaching intensity
Non 3.75 (2.9) 3.41 (2.5) 10.82 (9.4) 4.65 (3.4)
Low 3.82 (2.4) 3.78 (2.4) 10.51 (6.7) 5.14 (2.9)
High 2.96 (1.3) 0.55, .79 3.19 (1.2) 0.60, .55 8.16 (3.5) 0.57, .57 4.37 (1.8) 0.62, .54
Bedsize
<100 3.74 (3.7) 3.28 (3.5) 12.48 (14.8) 4.46 (4.6)
100---250 4.04 (2.7) 3.86 (2.5) 11.04 (7.4) 5.21 (3.1)
>250 3.02 (1.5) 2.40, .09 3.02 (1.4) 2.10, .12 8.45 (4.1) 2.40, .09 4.20 (1.9) 1.87, .16
NCI center
No 3.76 (2.7) 3.57 (2.4) 10.58 (8.1) 4.86 (3.1)
Yes 2.17 (0.7) 3.85, .01 2.58 (0.6) 0.82, .41 7.47 (4.6) 0.76, .45 3.51 (0.8) 2.81, .03
COC program
No 4.03 (3.2) 3.68 (2.9) 11.19 (9.8) 4.99 (3.7)
Yes 3.39 (1.8) 1.58, .12 3.41 (1.7) 0.73, .46 9.75 (5.5) 1.16, .25 4.66 (2.2) 0.68, .50
Performed advanced
procedures
No 4.00 (3.0) 3.65 (2.5) 11.36 (9.4) 4.98 (3.4)
Yes 3.22 (1.7) 2.15, .03 3.37 (2.2) 0.70, .48 8.97 (4.8) 2.16, .03 4.57 (2.5) 0.82, .41
Quartile of procedure
Volume
Lowest 4.30 (3.9) 3.67 (3.5) 12.49 (12.7) 5.01 (4.5)
Second 4.10 (2.7) 4.00 (2.4) 10.72 (6.1) 5.34 (3.0)
Third 3.36 (1.8) 3.30 (1.7) 10.10 (6.5) 4.52 (2.3)
Highest 3.11 (1.5) 1.95, .12 3.19 (1.3) 0.99, .40 8.70 (4.3) 1.58, .20 4.43 (1.8) 0.79, .50
Overall 3.72 (2.6) 3.55 (2.4) 10.50 (8.1) 4.83 (3.1)
T tests used when comparing outcome rates by NCI, COC and advanced procedures. Teaching status, bedsize, and procedure volume used T tests.
NCI, National Cancer Institute Clinical or Comprehensive Cancer Center; COC, Commission on Cancer Approved Cancer Program.
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Table III. Hospital characteristics as predictors of 30-day mortality and failure to rescue
30-day mortality
I II III
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
Teaching intensity
Non (n = 84) — — —
Low (n = 68) 0.89 (0.74–1.07) .20 0.93 (0.77–1.12) .45 1.00 (0.83–1.21) .95
High (n = 12) 0.71 (0.54–0.93) .01 0.81 (0.59–1.12) .21 1.03 (0.71–1.49) .87
Bedsize
<100 (n = 21) — — —
100--250 (n = 97) 1.05 (0.72–1.54) .81 1.07 (0.73–1.59) .71 1.00 (0.65–1.55) .98
>250 (n = 46) 0.85 (0.58–1.24) .40 0.90 (0.61–1.32) .58 0.88 (0.55–1.41) .61
NCI center (n = 4) 0.60 (0.5–0.72) <.01 0.64 (0.50–0.83) <.01 0.68 (0.47–0.97) .04
COC program (n = 79) 0.93 (0.76–1.14) .47 0.99 (0.81–1.21) .94 1.11 (0.88–1.40) .36
Advanced procedures (n = 59) 0.80 (0.68–0.96) .02 0.87 (0.72–1.04) .11 1.01 (0.79–1.29) .94
Quartile of procedure volume
Lowest (n = 41) — — —
Second (n = 42) 0.88 (0.64–1.20) .41 1.19 (0.86–1.64) .31 1.14 (0.81–1.62) .45
Third (n = 40) 0.75 (0.55–1.02) .07 0.94 (0.67–1.30) .69 0.91 (0.62–1.34) .65
Highest (n = 41) 0.64 (0.48–0.88) <.01 0.88 (0.65–1.20) .42 0.90 (0.59–1.39) .65
Model I: Unadjusted. Each hospital characteristic modeled separately. Model II: All patient characteristics modeled with each hospital characteristic
separately. Model III: All patient and hospital characteristics modeled simultaneously.
NCI, National Cancer Institute; COC, Commission on Cancer. All models adjusted standard errors to account for patient clustering in hospitals.
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rescue is that the outcome measure does not ‘‘pun-
ish’’ a hospital should a patient experience a com-
plication since complications are associated with
case mix severity; it merely identifies whether the
hospital rescued the patient successfully from the
complication. Following established proce-
dures,12,13 patients who died postoperatively were
assumed to have experienced a complication,
even if no complication was coded explicitly in
the discharge abstract. Thus, FTR includes all pa-
tients who died within 30 days of hospital admis-
sion. The denominator between 30-day mortality
and FTR differs. In the former, the denominator
is all patients in the sample, while in the latter,
the denominator is only patients who experience
a complication or who die within 30 days of
admission.
Statistical analysis. We tested bivariate relation-
ships between clinical severity and hospital char-
acteristics using the t, F, or Chi-square test, as
appropriate. We also calculated bivariate associa-
tions of hospital characteristics with unadjusted
and adjusted outcomes rates for hospitals. These
risk-adjusted rates were calculated using the ratio
of observed events (deaths or failures) divided by
the expected number of events predicted by the
risk adjustment model, multiplied by the sample’s
respective event rate. We ruled out multicollinear-
ity among hospital and nursing characteristics byexamining correlation matrices for high correla-
tions, and by yielding acceptable variance inflation
factor and tolerance values. We then performed a
patient-level analysis and estimated a series of lo-
gistic regression models to predict death and fail-
ure to rescue. First, models estimated the effect
of each hospital characteristic without additional
variables in the model. Next, models included
the 25 variables identified in the risk adjustment
model. Our final models considered all patient
and hospital characteristics simultaneously. Ro-
bust, cluster methods were specified in STATA
version 10.0 (Stata Corp., College Station, TX) to
adjust standard errors and account for patient
clustering in hospitals.27,28 Coefficients were trans-
formed to odds ratios, and 95 percent confidence
intervals were calculated for all parameter
estimates.
Sensitivity analyses: The analyses reported here
used a dichotomy of cancer program status; how-
ever, the COC reported separate categories based
on volume and teaching status. A sensitivity analysis
using the four categories revealed no differences in
our results. Because our sample is quite heteroge-
neous in tumor type, we also performed an analysis
of these variables stratified by volume-sensitive
tumors (pancreas, esophagus, and lung, versus all
others). We also replicated our findings for 30-day
mortality using a measure of 60-day mortality. Our
results and conclusions did not change appreciably.
Failure to rescue
I II III
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
— — —
0.83 (0.68–1.03) .20 0.88 (0.72–1.08) .23 0.97 (0.80–1.19) .79
0.67 (0.51–0.88) <.01 0.74 (0.53–1.02) .07 0.94 (0.64–1.37) .73
— — —
0.92 (0.59–1.44) .72 0.91 (0.59–1.40) .66 0.88 (0.55–1.42) .61
0.75 (0.49–1.17) .20 0.74 (0.48–1.14) .17 0.79 (0.47–1.35) .40
0.64 (0.47–0.86) <.01 0.67 (0.47–0.96) .03 0.76 (0.49–1.18) .23
0.95 (0.77–1.18) .66 0.99 (0.80–1.22) .92 1.17 (0.91–1.49) .22
0.83 (0.68–1.02) .08 0.84 (0.69–1.01) .07 1.02 (0.78–1.32) .91
— — — —
0.94 (0.68–1.31) .72 1.13 (0.81–1.60) .48 1.10 (0.77–1.57) .61
0.85 (0.60–1.20) .35 0.94 (0.65–1.34) .72 0.91 (0.60–1.38) .65
0.69 (0.49–0.96) .03 0.82 (0.59–1.14) .23 0.82 (0.52–1.32) .43
Table III. (continued)
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Clinical severity by hospital characteristics.
Table I presents differences in clinical severity
and cancer severity by hospital characteristics
(the clinical variables for the entire sample are
presented in the first column). The mean age of
the sample was 68.3 years, and approximately one
third of study patients were below the age of 65.
The majority of patients received colorectal or
prostate resections.
Admission severity and cancer severity differed
significantly by hospital characteristics. Patients in
hospitals with NCI cancer centers were of younger
age, and lower Atlas admission severity than in
other hospitals. NCI hospitals cared for a larger
proportion of ovarian, prostate, and pancreatic
cancer patients than non-NCI hospitals (results
not shown). The proportion of patients with
distant metastases was not significantly different
across hospitals. Similarly, the average length of
cancer diagnosis was 19.0 months, and did not
differ significantly by hospital characteristics (re-
sults not shown). Hospitals with COC Cancer
Program status had younger patients, yet slightly
more patients with metastatic cancer. When con-
trasted with lower volume hospitals, patients in
hospitals in the highest quartile of procedure
volume were younger, with fewer comorbidities,
and lower Atlas severity scores. Similar trends for
age and Atlas severity were observed for hospitals
of larger size, teaching intensity, and performance
of advanced procedures.Outcomes by hospital characteristics. Table II
shows the unadjusted and risk-adjusted outcome
rates based on hospital characteristics. These are
hospital-level outcome rates, with the adjusted
rates calculated by the proportion of observed
over expected events multiplied by the sample’s
overall mortality or failure to rescue rate. The over-
all hospital-level unadjusted rates of 30-day mortal-
ity and failure to rescue were 3.72%, and 10.5%,
respectively. T and F tests were used to compare
outcomes rates across hospital characteristics with
2 or 3 or more strata, respectively. While outcomes
are uniformly better in hospitals with NCI cancer
center designation, the only significant differences
were found when comparing unadjusted 30-day
mortality rates (P < .01), and adjusted failure to
rescue rates (P = .03). Hospitals performing ad-
vanced procedures, such as organ transplantation
or coronary artery bypass graft operations, had sig-
nificantly lower unadjusted death and FTR (both
P = .03). These differences were no longer signifi-
cant when outcome rates were adjusted for severity
of illness. Significant differences in outcome rates
based on COC cancer program approval, teaching
status, or hospital procedure volume were not
observed.
Predictors of patient outcomes. Table III shows
the results of logistic regression models to predict
30-day mortality and failure to rescue from the pa-
tient-level data. For both outcomes, 3 series of
models are presented: in column I, each hospital
characteristic’s unique odds ratio on the outcome
Surgery
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all patient characteristics with each hospital char-
acteristic separately, and column III reflects all pa-
tient and hospital characteristics simultaneously
specified in 1 model.
From the first series of models, significant pre-
dictors of 30-day mortality included high teaching
intensity (OR, 0.71; 95% CI, 0.54--0.93), NCI cancer
center (OR, 0.60; 95% CI, 0.50--0.72), advanced
procedure hospitals (OR, 0.80; 95% CI, 0.68--0.96),
and highest quartile of procedure volume (OR,
0.64; 95% CI, 0.48--0.88). Models estimating failure
to rescue found similar effects for high teaching
intensity, NCI cancer centers, and highest proce-
dure volume. In the results for Model II, where
patient characteristics were modeled with each
hospital characteristic, the only hospital character-
istic that significantly predicted outcomes when
patient severity was considered was NCI cancer
center (30-day mortality OR, 0.64; 95% CI, 0.50--83;
FTR OR, 0.67; 95% CI, 0.47--0.96). From Model III,
the only variable to predict 30-day mortality when all
patient and hospital characteristics were simulta-
neously considered was NCI cancer center (OR,
0.68; 95% CI, 0.47--0.97). No hospital characteristics
significantly predicted the odds of failure to rescue
when all characteristics were considered.DISCUSSION
We report significant differences in clinical
severity, cancer severity, and outcomes for surgical
oncology patients by hospital characteristics. Con-
trary to what might be expected, severity of illness
does not appear uniformly higher in NCI cancer
centers. However, NCI cancer centers in our study
achieved lower mortality rates than would be
expected on the basis of case mix. In other types
of hospitals studied, more favorable mortality rates
were found to be largely a product of less severely
ill patients. The absence of outcome differences by
COC status, either adjusted or unadjusted, sug-
gests that Commission on Cancer standards in
place at the time of the study did not convey a
direct outcome benefit for patients in this study.
It would be worthy to re-examine this question in
additional datasets because COC standards have
changed over time. It is also possible that many
hospitals could meet COC standards, but elected
not to obtain formal program approval. This would
result in few actual differences between the COC
and non-COC hospitals in our sample.
Patient and provider selection are two other
explanations for these observations. Younger pa-
tients may feel compelled to travel outside theirimmediate area and seek facilities or providers
based on reputation. In a study of chemotherapy
outcomes, patients who traveled greater than 15
miles for treatment had superior survival to pa-
tients treated locally.29 Alternately, physicians in
hospitals with higher teaching intensity, advanced
resources, and higher volumes may deem patients
too frail to undergo operations and instead recom-
mend less invasive management. Our data are
from 1998 and 1999; this is because of the unique
linkage of datasets that are not routinely available
to investigators. While the procedures studied at
the time are common operations for cancer, con-
firmation of our results in more contemporary
samples, coupled with the measurement of process
of care variables, would be a useful addition to this
area of research.
Our inability to detect significant outcome dif-
ferences on hospital characteristics may be due to
the coarseness of some measurements. For exam-
ple, knowledge of individual physician character-
istics such as provider volume, training, and board
certification could refine our approach.6 Because
our initial study was not designed to examine
the volume-outcome relationship a priori, we
have small numbers of tumor types where vol-
ume-outcome relationships have been previously
documented. Thus, these findings should be inter-
preted with caution, yet application of the risk
adjustment methods used in this study could be
applied in the future to larger samples of these pa-
tients. Other important outcomes, such as recur-
rence, late survival, costs, and subsequent health
care utilization, were not examined in this study
due to data availability. While we had a large num-
ber of hospitals in our analysis, not all acute care
hospitals in Pennsylvania were included because
of missing claims or administrative data. We were
unable to adjust our analysis for prior receipt of
chemo- or radiotherapy, or consider any care pro-
vided outside the Commonwealth of Pennsylvania.
While only 4 hospitals with NCI status were in our
sample, they accounted for 7% of the patient sam-
ple. Confirmation of our findings in more hospi-
tals with and without NCI status is suggested.
However, our study contributes to the cancer out-
comes research literature by extending the analysis
outside of the Medicare-eligible population. When
compared with other cancer outcomes study fo-
cused on hospital differences, we included both
admission severity and cancer severity in our
models. While most studies report adjustment for
age, sex, and comorbidities, we have described
our analytic approach and model discrimination
statistics in greater detail. Cancer severity variables
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gest predictors of outcomes in our severity adjust-
ment models; these measures are often not
available in traditional claims-based analyses. Data-
sets that combine claims, tumor registry, and phys-
iologic variables, such as the National Surgical
Quality Improvement Program,30 are optimal tar-
gets for replication of our analyses. However, a
challenge remains to study structure, process,
and outcomes in hospitals that do not participate
in voluntary data collection efforts.
In conclusion, hospitals with high teaching in-
tensity, capabilities to perform advanced proce-
dures, and national credentials were not always
caring for the sickest patients. After risk adjustment,
few hospital characteristics were significantly associ-
ated with 30-day mortality or failure to rescue. Our
report underscores the necessity for robust risk
adjustment in cancer outcomes research, and ex-
plicit reporting of risk adjustment procedures in
publications. From the management and policy
perspectives, recommendations to reorganize on-
cology surgical care based on these factors should
await further confirmation. Our confirmation of
favorable benefits to patients who receive care in
National Cancer Institute-designated cancer centers
should prompt additional research into underlying
differences in care processes in these institutions.
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